Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 34

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
8,543,686 issued and outstanding at June 30, 2025 and December 31, 2024, respectively *9 9 Additional paid-in capital241,248 238,685 Accumulated deficit(256,042)(251,421)Accumulated other comprehensive loss10 10 Total Stockholders’ Deficit(14,775)(12,717)Total Liabilities and Stockholders’ Deficit$33,046 $30,119 

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

4

Table of Contents

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(In thousands, except share data)

Three Months Ended June 30,Six Months Ended June 30,2025202420252024Revenue$10,164 $7,162 $19,506 $12,948 Cost of Revenues2,206 1,922 4,164 3,506 Gross Margin7,958 5,240 15,342 9,442 Operating Expenses:General and administrative4,039 1,839 8,506 5,514 Selling and marketing1,674 1,034 3,205 2,266 Research and development194 195 402 358 Depreciation and amortization174 180 366 362 Total Operating Expenses6,081 3,248 12,479 8,500 Operating Income1,877 1,992 2,863 942 Other Income (Expense):Interest expense(1,874)(3,396)(3,726)(6,633)Interest expense, related party- (387)— (710)Gain on extinguishment of debt- 5,310 — 5,205 Change in fair value of derivative liabilities990 3,717 (3,911)1,216 Other expense(27)(685)(28)(787)Other income89 10 181 2,800 Total Other Income (Expense)(822)4,569 (7,484)1,091